Multiscale Modeling / Simulation of the Response to Pulmonary Stereotactic Hypofractionated Irradiation
试验速览
- 阶段
- 不适用
- 入组人数
- 60
- 试验地点
- 4
- 主要终点
- Kinetics of PET-CT parameters : metabolic tumor volume
研究概览
简要总结
Identify 18-Fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography (PET-CT) parameters predictive of tumor response and local control
详细描述
The identification of robust prognostic and predictive markers could allow the individualization of pulmonary stereotactic radiotherapy treatments and the selection of patients at high risk of relapse, who could then benefit from a dose escalation in order to increase the chances of local control .
Beyond the pulmonary RTS (Radiotherapy in stereotactic condition), this study will aim to generate one or more models of multi-scale response to hypofractionated irradiation from biomarkers (biological or images) extracted from preclinical or clinical literature data and to allow simulations of Various modified fractionation irradiation schemes, potentially leading to new regimens that reduce side effects and increase therapeutic efficacy.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age> 18 years
- •Performance Index WHO (World Health Organization) ≤ 2
- •Bronchopulmonary carcinoma not in small cells proved histologically or cytologically (epidermoid, adenocarcinoma, or large cell carcinoma).
- •Tumor classified T1 - T2 (Tumor=1-2) N0 (Node=0) M0 (Metastasis=0) and diameter ≤ 5 cm or Tumor classified T3 (≤5cm) N0M0 of the chest wall
- •Tumor located more than 2 cm from the trachea and bronchus stem and more than 1.5 cm from the organs at risk
- •Medically inoperable or refusing surgery
- •Indication of stereotactic radiotherapy validated in multidisciplinary consultation meeting
- •Formulation of consent
排除标准
- •Age <18 years.
- •History of pulmonary irradiation
- •Pulmonary surgery of the tumor
- •Different histology of non-small cell carcinoma
- •Patient with a T2 or T3> 5 cm tumor or patients with a T3 tumor invading a structure other than the chest wall
- •Patient with a tumor within 2 cm of the trachea and bronchus stem and within 1.5 cm of the organs at risk in the proximal area of the no fly zone (defined as a volume Located 2 cm in all directions of the proximal bronchial tree - Pulmonary metastases
- •Declared pregnancy, breast-feeding
- •Refusal to use effective contraception
- •Against indication to the realization of the PET to the 18FDG (18-fluorodeoxyglucose)(uncontrolled diabetes)
- •Refusal or inability to consent to participate in the study.
- •Estimated life expectancy <2 months in the absence of treatment
- •Other invasive tumors diagnosed in the previous 2 years, with the exception of non-melanocytic cutaneous carcinomas.
结局指标
主要结局
Kinetics of PET-CT parameters : metabolic tumor volume
时间窗: 2 years
Metabolic tumor volume (MTV) will be measured before and after stereotactic irradiation.
Local control
时间窗: 2 years
Local control defined by the absence of progression in the irradiated area
Kinetics of PET-CT parameters : standardized uptake value (SUV) max
时间窗: 2 years
SUV max will be measured before and after stereotactic irradiation.
Tumor metabolic response
时间窗: 2 years
Tumor metabolic response, as assessed on 18F-FDG PET-CT at 6 months of end of radiotherapy
Kinetics of PET-CT parameters : texture parameters :quantitative extraction of images by specific software
时间窗: 2 years
The first-order form parameters and statistical parameters, the second order (based on the matrix of co-occurrence of the grey levels and the matrix of differences of grey levels) and of the third order (based on the matrices of alignment of the grey levels and the matrices of sizes of zones) will be studied.
次要结局
- Predictive power of metabolic imaging parameters for tumor response and local control Predictive power of metabolic imaging parameters for tumor response and local control(2 years)
- Survival in disease(2 years)
- Predictive power of serum markers for tumor response and local control(2 years)
- Survival without metastasis at a distance(2 years)
- Kinetics of serum markers(2 years)
- Radiation-induced toxicity(2 years)
- Correlation between these parameters(2 years)